OA-06 Robust in vivo expansion and long-term persistence of anti-BCMA CAR T cells, PHE885, manufactured in <2 days on the T-Charge platform
Clinical Lymphoma, Myeloma & Leukemia(2023)
关键词
vivo expansion,phe885,long-term,anti-bcma,t-charge
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要